You are here: Industry Insights > Frost & Sullivan

News List

Sunquest Earns Frost & Sullivan's Company of the Year Award for its End-to-End Lab Diagnostics IT Solutions prnasia
March 29, 2018
Sunquest's health information technology (HIT) offerings address the workflow, connectivity, and interoperability issues occurring in today's changing healthcare landscape
Frost & Sullivan Publishes Update Coverage Report on BiolineRx Ltd.: Continued advancement and execution of BiolineRx's lead oncology project prnasia
March 27, 2018
TASE analysis project was launched in 2016 in order to raise the investors' level of knowledge of TASE listed technology and life-science companies and the markets in which the companies operate
Immuno-oncology Therapeutics Market to Reach $3.9 Billion by 2022, Finds Frost & Sullivan prnasia
March 20, 2018
Frost & Sullivan's latest analysis, Immuno-oncology Therapeutics Market -- Adoptive T-cell Therapies, Forecast to 2022, finds that the market is expected to generate revenues of $3.9 billion by 2022
Frost & Sullivan Applauds STANLEY Healthcare's Future-Ready and Industry-Leading Solutions for the S prnasia
January 17, 2018
Based on its recent analysis of the market for technology solutions for senior living communities, Frost & Sullivan recognizes STANLEY Healthcare with the 2017 Global Company of the Year Award
Frost & Sullivan Recognizes Caradigm as a Product Leader for its Value-based Care Management IT Solu prnasia
December 13, 2017
Frost & Sullivan Based on an analysis of the healthcare IT Value Care Management industry, Caradigm presented its 2017 North American Product Leadership Award for its comprehensive healthcare IT solutions portfolio
Smart Hospitals to Invest over $11 billion in Cloud Computing and Data Analytics, Says Frost & Sulli prnasia
December 11, 2017
By 2025, 10 percent of hospitals across the globe will become or will have started implementations to become smart hospitals.
OmniActive Health Technologies wins Frost & Sullivan 2017 North American Product Leadership Award pharmaasia
November 01, 2017
Clinical trials have demonstrate that the OmniActive Lutemax® 2020 offers eye, skin, and brain health benefits formulated from a single ingredient.
WuXi AppTec Receives 2017 Global Integrated Drug R&D Services Competitive Strategy Innovation & Lead prnasia
October 09, 2017
The award is part of the Frost & Sullivan Best Practices Award series, which recognizes best-in-class companies that have demonstrated excellence in their respective industries.
Frost & Sullivan Commends Credence ID's Rollout of CredenceTAB(TM), a Biometric Tool that Combines D en-cphi.cn
August 02, 2017
Credence ID's unique product suite offers convenience, portability, and customization to satisfy a wide range of identification projects
Frost & Sullivan Commends Impinj for Aiding Healthcare Providers' Asset Tracking Efforts with its No en-cphi.cn
June 28, 2017
Impinj's holistic solution streamlines the supply chain of healthcare delivery organizations and greatly optimizes their asset and labor utilization

Previous page 1 2 3 4 5 Next page